» Articles » PMID: 38318575

Circulating Tumor Cells in Oral Cancer

Overview
Journal Cureus
Date 2024 Feb 6
PMID 38318575
Authors
Affiliations
Soon will be listed here.
Abstract

Till now, oral squamous cell carcinoma (OSCC) is graded as well-differentiated, moderately-differentiated, poorly-differentiated, and undifferentiated. However, this grading does not have a prediction of the prognosis of the patient. Also, prognosis impacts lymph node metastases, surgical margins, and vascular invasions (neural invasion, muscular invasion, salivary gland invasion). The prognosis of lymph node metastases is significant, which affects the survival of the patients which is 50%. So, a dependable blood marker is needed for prognosis in OSCC patients with loco-regional and distant recurrence. Some factors can be assisted only after surgery and invasive techniques to check the prognosis of the disease. Despite the ease of examining the oral cavity, there is no practical approach for non-invasive screening and detecting cancer. As it is abrupt to use such invasive procedures from time to time, there is a need for nonsurgical and reliable techniques to assess the progression of tumors. Also, frozen sections are helpful during the intraoperative procedure to evaluate the lymph node metastases. An increase in the number of tumor cells through blood is a significant event in disease metastases toward the peripheral blood. Oral health impact assessment instruments could aid in determining the quality of life, and their usage in the initial stages of oral carcinoma could help physicians choose the best treatment option for enhancing the quality of life.

Citing Articles

PADI4 expression in baseline circulating tumour cells acts as a prognostic biomarker in oral squamous cell carcinoma.

Chauhan A, Boora G, Maitra A, Gupta R, Bakshi J, Ghoshal S J Liq Biopsy. 2025; 7:100289.

PMID: 40027234 PMC: 11863982. DOI: 10.1016/j.jlb.2025.100289.


Distant metastasis of oral squamous cell carcinoma: immune escape mechanism and new perspectives on treatment.

He L, Wan M, Yang X, Meng H Discov Oncol. 2025; 16(1):257.

PMID: 40024975 PMC: 11872995. DOI: 10.1007/s12672-025-01997-3.

References
1.
Powell A, Talasaz A, Zhang H, Coram M, Reddy A, Deng G . Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS One. 2012; 7(5):e33788. PMC: 3346739. DOI: 10.1371/journal.pone.0033788. View

2.
Hristozova T, Konschak R, Stromberger C, Fusi A, Liu Z, Weichert W . The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN). Ann Oncol. 2011; 22(8):1878-85. DOI: 10.1093/annonc/mdr130. View

3.
Kusukawa J, Suefuji Y, Ryu F, Noguchi R, Iwamoto O, Kameyama T . Dissemination of cancer cells into circulation occurs by incisional biopsy of oral squamous cell carcinoma. J Oral Pathol Med. 2000; 29(7):303-7. DOI: 10.1034/j.1600-0714.2000.290703.x. View

4.
Bagri-Manjrekar K, Chaudhary M, Sridharan G, Tekade S, Gadbail A, Khot K . autofluorescence of oral squamous cell carcinoma correlated to cell proliferation rate. J Cancer Res Ther. 2018; 14(3):553-558. DOI: 10.4103/0973-1482.172710. View

5.
Cristaldi M, Mauceri R, Di Fede O, Giuliana G, Campisi G, Panzarella V . Salivary Biomarkers for Oral Squamous Cell Carcinoma Diagnosis and Follow-Up: Current Status and Perspectives. Front Physiol. 2020; 10:1476. PMC: 6914830. DOI: 10.3389/fphys.2019.01476. View